ALBO
Albireo Pharma Inc
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
41 hedge funds and large institutions have $19.3M invested in Albireo Pharma Inc in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less capital invested
Capital invested by funds: $32.9M → $19.3M (-$13.6M)
Holders
41
Holding in Top 10
–
Calls
$870K
Puts
$258K
Top Buyers
| 1 | +$1.17M | |
| 2 | +$1.08M | |
| 3 | +$436K | |
| 4 |
Renaissance Technologies
New York
|
+$332K |
| 5 |
Two Sigma Investments
New York
|
+$231K |
Top Sellers
| 1 | -$4.99M | |
| 2 | -$4.2M | |
| 3 | -$916K | |
| 4 |
O
OrbiMed
New York
|
-$798K |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$709K |